Considering potential impurities from inferior sight glasses in pharma manufacturing
The FDA’s newest guidelines on elemental impurities will have significant implications for drug makers and their suppliers.
The FDA’s newest guidelines on elemental impurities will have significant implications for drug makers and their suppliers.